KR102055492B1 - 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제 - Google Patents

여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제 Download PDF

Info

Publication number
KR102055492B1
KR102055492B1 KR1020177034741A KR20177034741A KR102055492B1 KR 102055492 B1 KR102055492 B1 KR 102055492B1 KR 1020177034741 A KR1020177034741 A KR 1020177034741A KR 20177034741 A KR20177034741 A KR 20177034741A KR 102055492 B1 KR102055492 B1 KR 102055492B1
Authority
KR
South Korea
Prior art keywords
delete delete
magnesium
taurine
acne
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020177034741A
Other languages
English (en)
Korean (ko)
Other versions
KR20180004202A (ko
Inventor
마가렛 진 프로펫
Original Assignee
마가렛 진 프로펫
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마가렛 진 프로펫 filed Critical 마가렛 진 프로펫
Publication of KR20180004202A publication Critical patent/KR20180004202A/ko
Application granted granted Critical
Publication of KR102055492B1 publication Critical patent/KR102055492B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020177034741A 2015-06-17 2016-06-10 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제 Expired - Fee Related KR102055492B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562180842P 2015-06-17 2015-06-17
US62/180,842 2015-06-17
PCT/US2016/037050 WO2016205089A1 (en) 2015-06-17 2016-06-10 Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197036101A Division KR20190137971A (ko) 2015-06-17 2016-06-10 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제

Publications (2)

Publication Number Publication Date
KR20180004202A KR20180004202A (ko) 2018-01-10
KR102055492B1 true KR102055492B1 (ko) 2019-12-12

Family

ID=57546606

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020177034741A Expired - Fee Related KR102055492B1 (ko) 2015-06-17 2016-06-10 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제
KR1020197036101A Withdrawn KR20190137971A (ko) 2015-06-17 2016-06-10 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197036101A Withdrawn KR20190137971A (ko) 2015-06-17 2016-06-10 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제

Country Status (9)

Country Link
US (2) US9795633B2 (https=)
EP (1) EP3310366A4 (https=)
JP (2) JP6657394B2 (https=)
KR (2) KR102055492B1 (https=)
CN (1) CN107708708A (https=)
AU (1) AU2016278939B2 (https=)
CA (1) CA2987293C (https=)
MX (1) MX365366B (https=)
WO (1) WO2016205089A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642877B1 (en) * 2016-01-06 2017-05-09 Kenneth O. Russell Method of administration of chromium and magnesium sulfate for treatment of acne
WO2016205089A1 (en) * 2015-06-17 2016-12-22 Profet Margaret Jean Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN107049890B (zh) * 2017-06-27 2020-04-03 广东芭薇生物科技股份有限公司 一种具有舒缓抗粉刺功效的护肤品
KR102310566B1 (ko) 2018-05-21 2021-10-08 랩앤피플주식회사 여드름 완화 및 예방용 패치
WO2019225948A1 (ko) * 2018-05-21 2019-11-28 랩앤피플주식회사 여드름 완화 및 예방용 패치
KR102651395B1 (ko) * 2018-07-05 2024-03-26 랩앤피플주식회사 여드름 완화 및 예방용 화장품 조성물
EP3738588A1 (en) 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
CN113840614A (zh) 2019-05-16 2021-12-24 瑟纳法姆工业合成有限公司 用于治疗经前综合征和/或经前焦虑症的化合物和组合物
PL3738596T3 (pl) * 2019-05-16 2022-07-04 Synapharm Industrial Synthesis Związek i kompozycja do stosowania w leczeniu zespołu napięcia przedmiesiączkowego i/lub przedmiesiączkowego zaburzenia dysforycznego
WO2024118480A1 (en) * 2022-11-28 2024-06-06 Epiphany Biosciences Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130337086A1 (en) * 2009-04-15 2013-12-19 Bmg Pharma Llc Mineral salt-sulfonic acid compositions and methods of use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (fr) 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US4545977A (en) 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
CN1126596A (zh) * 1995-01-11 1996-07-17 徐富中 一种治疗粉刺的制剂
US5776498A (en) 1995-11-06 1998-07-07 Nutrition 21 Magnesium taurate as an adjuvant to rapid thrombolytic therapy
US5582839A (en) 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates
US5962517A (en) 1997-01-31 1999-10-05 Murad; Howard Pharmaceutical compositions and methods for treating acne
US6558656B2 (en) 2000-04-20 2003-05-06 Morris Mann Oral and topical compositions and methods related thereto in the treatment of acne
US20040039042A1 (en) 2002-08-23 2004-02-26 Fleming Thomas E. Method of transdermal drug delivery
US20040214891A1 (en) 2003-04-22 2004-10-28 Janusz Marcinkiewicz Method for inhibiting pathogenic bacteria and fungi growth and microbicidal composition
US20050008684A1 (en) 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
US7258875B2 (en) * 2003-12-04 2007-08-21 Chiou Consulting, Inc. Compositions and methods for topical treatment of skin infection
US20070207228A1 (en) * 2004-03-02 2007-09-06 Giammaria Giuliani Composition for Regulating the Trophism of Hair Follicles and the Cutaneous Production of Sebum and Use Thereof in Androgenic Alopecia
US20060193922A1 (en) 2005-02-25 2006-08-31 Natalia Neikrug Compositions and methods for the treatment of acne
US7955610B2 (en) 2005-08-04 2011-06-07 National Science And Technology Development Agency Antimicrobial composition for topical application and a method thereof
MX2009001533A (es) * 2006-08-11 2009-02-18 Panacea Biotec Ltd Particulas para el suministro de ingredientes activos, procedimiento de elaboracion y sus composiciones.
WO2010009369A2 (en) * 2008-07-17 2010-01-21 Georgia Levis Methods and materials for the treatment of acne
US20140121188A1 (en) * 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
MX368853B (es) * 2014-07-01 2019-10-18 CHACON Enrique Composiciones y métodos tópicos para el tratamiento de heridas.
WO2016205089A1 (en) * 2015-06-17 2016-12-22 Profet Margaret Jean Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130337086A1 (en) * 2009-04-15 2013-12-19 Bmg Pharma Llc Mineral salt-sulfonic acid compositions and methods of use

Also Published As

Publication number Publication date
JP2018517787A (ja) 2018-07-05
AU2016278939B2 (en) 2018-11-08
MX365366B (es) 2019-05-30
JP2020073587A (ja) 2020-05-14
US10342823B2 (en) 2019-07-09
CA2987293A1 (en) 2016-12-22
US20180036340A1 (en) 2018-02-08
JP6657394B2 (ja) 2020-03-04
EP3310366A4 (en) 2019-01-02
EP3310366A1 (en) 2018-04-25
KR20190137971A (ko) 2019-12-11
CA2987293C (en) 2020-11-03
WO2016205089A1 (en) 2016-12-22
US9795633B2 (en) 2017-10-24
US20160367596A1 (en) 2016-12-22
CN107708708A (zh) 2018-02-16
AU2016278939A1 (en) 2017-12-07
KR20180004202A (ko) 2018-01-10
MX2017015012A (es) 2018-08-15

Similar Documents

Publication Publication Date Title
KR102055492B1 (ko) 여드름을 예방 및 치료하기 위한 타우린 및 마그네슘을 포함하는 국소 및 경구 제제
US20070292493A1 (en) Pharmaceutical composition and method for the transdermal delivery of calcium
JP2002543106A (ja) 抗悪心組成物および方法
US20150216823A1 (en) Compositions for the treatment of migraine headaches and methods thereof
JPH04243825A (ja) 色素沈着症治療剤
US20030125303A1 (en) Transdermal formulation for repair and maintenance of connective tissue
WO2010036977A2 (en) Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
US20050196469A1 (en) Micronutrient supplement combination for acne treatment and prevention
US20110256237A1 (en) Methods and compositions for treating acne vulgaris and acne rosacea
CN110891561A (zh) 治疗痤疮的方法和组合物
WO2018071656A1 (en) Formulations for treatment of migraines
JP4553552B2 (ja) 生体リズム応用キット
EP3738588A1 (en) Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
US20190262390A1 (en) Topical and oral formulations comprising taurine and magnesium for the treatment of rosacea
US20220160619A1 (en) Effervescent Drug Formulations
De Ruiter et al. Trifarotene (Aklief, Galderma)
US20130059813A1 (en) Treatment of dermatological conditions
US20180193312A1 (en) Nutraceutical composition and dosing regimen
CN106265112A (zh) 促进伤口愈合的药物、化妆用组合物和食品添加剂
JP2026012002A (ja) 鉄欠乏性貧血に伴って悪化する肌質、髪質又は爪質の改善用医薬組成物
CHiLOREN Debulk advanced ovarian cancer before or after chemo
JPH0449238A (ja) 皮膚疾患治療薬

Legal Events

Date Code Title Description
A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20221207

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20221207